Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole vs Bromocriptine in Parkinson's Disease
NCT00240409Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2003
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started Jul 2003; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00240409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240409.